Understanding GDF Proteins for Heart Health
Myocardial Physiology of Growth Differentiation Factor Signaling
This research explores how two proteins, GDF11 and GDF8, affect heart health and why their levels in the blood might predict future heart problems for people with coronary heart disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11092220 on NIH RePORTER |
What this research studies
We are learning more about two important proteins, GDF11 and GDF8, which play a role in how the heart grows and functions. Our recent findings show that if you have coronary heart disease, low levels of these proteins in your blood could indicate a higher risk of future health issues. We also know that changes in the GDF11 protein can lead to heart problems and other health conditions in people. By understanding how these proteins work differently and how they signal within the body, we hope to uncover new ways to help protect your heart.
Who could benefit from this research
Good fit: Patients with coronary heart disease, especially those with low blood levels of GDF8 and GDF11, might be ideal candidates for future related studies.
Not a fit: Patients without heart conditions or whose heart issues are not related to GDF11 or GDF8 signaling may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to identify individuals at higher risk for heart problems and potentially develop new treatments that target these important proteins.
How similar studies have performed: While the specific differences between GDF11 and GDF8 potency are a recent discovery, the broader field of growth factor signaling in heart disease has been a focus of ongoing research.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Lee, Richard T — Harvard University
- Study coordinator: Lee, Richard T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.